Posted by Michael Wonder on 05 Dec 2019
FDA launches app for health care professionals to report novel uses of existing medicines for patients with difficult-to-treat infectious diseases
5 December 2019 - The U.S. FDA today announced the global launch of CURE ID, an internet-based repository that will allow the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs through a website, a smartphone or other mobile device.
The platform enables the crowdsourcing of medical information from health care providers to guide potentially life-saving interventions and facilitate the development of new drugs for neglected diseases.
The repository is a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH).
